The BACE1 Knockout SK-HEP-1 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population designed to eliminate beta-secretase 1 (BACE1) expression in the human SK-HEP-1 hepatic adenocarcinoma cell line. This product provides a heterogeneous pool of gene-edited cells with targeted disruption of the BACE1 gene, enabling loss-of-function studies without the selection of a single clone. As a polyclonal knockout model, it preserves the inherent genetic diversity of the parental population while uniformly ablating BACE1 activity, making it suitable for robust, reproducible experiments.
The SK-HEP-1 host cell line originates from the ascitic fluid of a patient with liver adenocarcinoma and displays a unique combination of epithelial and endothelial markers. This cell line serves as a versatile model for hepatocellular carcinoma research, yet also exhibits characteristics such as expression of endothelial adhesion molecules and capacity for angiogenic signaling, expanding its utility into vascular biology. The dual nature of SK-HEP-1 cells provides a distinctive platform for investigating the intersection of hepatic cancer biology and endothelial cell functions.
BACE1 encodes the beta-secretase enzyme responsible for the initial cleavage of the amyloid precursor protein (APP) to generate the C99 fragment and soluble APP?? (sAPP??), a prerequisite step for subsequent gamma-secretase-mediated production of amyloid-beta (A??) peptides. Transcriptionally, BACE1 is regulated by NF-??B and Sp1 in response to hypoxia, oxidative stress, and inflammatory cytokines. The enzyme interacts with APP, presenilin, nicastrin, reticulon proteins, and ADP-ribosylation factor 6 within subcellular microdomains to coordinate proteolytic processing. Beyond APP, BACE1 also cleaves neuregulin-1, implicating it in myelination and synaptic signaling pathways. Loss of BACE1 abrogates A?? generation and disrupts neuregulin-1 processing, simultaneously affecting multiple downstream signaling cascades.
In the SK-HEP-1 background, BACE1 knockout eliminates the cell-intrinsic production of A?? peptides, creating a clean system for dissecting APP metabolism in a non-neuronal context. This model is particularly valuable for evaluating cell-type-specific roles of beta-secretase activity, as SK-HEP-1 cells express relevant cofactors such as the gamma-secretase complex components presenilin and nicastrin. The knockout also perturbs neuregulin-1 downstream signaling, which may impact cellular processes related to the cell line??s endothelial-like properties, including adhesion and migration. Researchers can use this system to study the consequences of BACE1 loss independently of neuronal contaminants.
Typical applications include high-throughput screening of BACE1 inhibitors, mechanistic dissection of APP processing steps, and validation of therapeutic antibodies targeting A??. The cells can be employed in western blotting to assess BACE1 and APP cleavage products, ELISA-based quantitation of secreted A??40/42, RT-qPCR for BACE1 transcript levels, beta-secretase enzymatic activity assays, and immunofluorescence to examine APP subcellular localization. This model also supports functional studies on neuregulin-1 processing and its impact on signaling outcomes. For additional information or to explore custom applications, please contact Ascent Research.
